- About NephU
- Meet The Team
- Supporting Organizations
- Community Advisors
- Contact Us
- Diversity, Equity, & Inclusion
- Resource Center
- Rare Kidney Diseases (PKD, IgAN, & Others)
- Kidney Disease & Mental Health
- Kidney Disease & Comorbid Conditions
- Transplantation & Dialysis
- NephU Nutrition & The NephChefTM
- Patient Resources
About This Event
Living Kidney Donation: One Solution For Patients With End-Stage Kidney Disease
Join us as we discuss the challenges patients with end-stage kidney disease face and explore the barriers and benefits of living kidney donation. Our speaker, Glenna Frey, APRN-CNS, is an advanced practice provider with over 35 years of nephrology nursing and oncology experience. Apart from being a healthcare provider, Glenna Frey is the co-founder and co-executive director of Kidney Donor Conversations, a non-profit that provides education about living kidney donation – a true passion of hers, as Glenna herself, is a living kidney donor.*Glenna Frey is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Drs Bigley and Green are employees of OPDC.
Kidney Donor Conversations, Inc.*
Glenna Frey, APRN-CNS, an advanced practice provider, will be discussing living kidney donation from a professional and personal perspective. Glenna received her BSN from Bowling Green State University and her MSN from the Medical College of Ohio. Glenna’s impressive career, includes positions of increasing responsibility in nursing practice with quality, clinical, education, consultation and research. Her dedication to the field is evident with over 35 years of nephrology nursing experience and is an active America Nephrology Nursing Association (ANNA) member. Currently, Glenna is a Healing Care Practitioner assisting outpatient oncology patients with relaxation, guided imagery, aromatherapy, and Healing Touch.
Apart from being a healthcare provider, Glenna is co-founder & co-Executive Director of Kidney Donor Conversations, Inc., a nonprofit founded in 2018 to provide education about living kidney donation – a true passion of hers, as Glenna herself, is a living kidney donor.
Otsuka Pharmaceutical Companies (U.S.)*
Dr Bigley is an Associate Director in the State Government Affairs and Advocacy division at Otsuka America Pharmaceutical, Inc. Dr Bigley received her doctoral degree in Public Health Leadership from the University of Illinois at Chicago and her Master’s degree in Public Health from East Stroudsburg University. She has worked in the pharmaceutical industry for over 27 years holding various positions in marketing, patient support/reimbursement and government affairs. As part of her role in state government affairs, she is responsible for engaging stakeholders on Otsuka’s policy platforms in multiple states.
Dr Bigley is a member of the PKD Foundation, actively serves in advocacy efforts supporting renal disease awareness and has served as the Renal Point for the State Government Affairs Team.
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Jill A Green, PhD, is a Clinical & Scientific Director in the nephrology division at Otsuka Pharmaceutical Development & Commercialization, Inc. Dr Green received her PhD in biomedical sciences, with a specialization in biochemical and molecular basis of disease. She went on to hold a research scientist role at The James Comprehensive Cancer Center at The Ohio State University, specializing in oncology pre-clinical research before taking a position as a Regulatory Compliance Officer where she managed thoracic oncology clinical trials at The James Cancer Hospital.
Dr Green has been a proud member of the PKD Foundation – Columbus, Ohio chapter for over 12 years where she has been active in fundraising and advocacy efforts.
If you would like to register for the 9:00 pm to 10:00 pm EDT broadcast, please click below:
Downloadable Resource July 15, 2022
This downloadable resource provides an overview of the PKD Foundation’s Centers of Excellence Program.
On-Demand Webinar October 15, 2020
The following on-demand Webinar discusses living kidney donation and the challenges patients with end-stage kidney disease face. It also explores the barriers and benefits of living kidney donorship.
Article July 6, 2020
The following is a summary of Wang, J. Current Status of Kidney Transplant Outcomes: Dying to Survive. Adv Chronic Kidney Dis. 2016;23(5):281-286. which was developed independently of the article authors….
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.May 2020 MRC2.CORP.X.04767
January 31 from 12:00 pm to 1:00 pm
February 14 from 12:00 pm to 1:00 pm
- Resource Center
- Patient Resources